CelLBxHealth PLC (CLBX)
Industry Diagnostics & Research
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
2.30p
Buy
2.50p
-0.25p (-9.43%)
Prices updated at 28 Oct 2025, 16:18 GMT
| Prices minimum 15 mins delay
Prices in GBX
ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 62.16 |
| 2023 | 69.90 |
| 2022 | 58.89 |
| 2021 | 70.19 |
| 2020 | 78.35 |
| 2019 | 77.14 |
| 2018 | 73.09 |
| 2017 | 75.30 |
| 2016 | 70.36 |
| 2015 | - |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 1.48 |
| 2024 | 13.38 |
| 2023 | 16.76 |
| 2022 | 104.41 |
| 2021 | 288.34 |
| 2020 | 89.98 |
| 2019 | 126.14 |
| 2018 | 59.31 |
| 2017 | 81.75 |
| 2016 | 79.49 |
| 2015 | - |
Price/Forward earnings (YTD)
-2.45
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -50.23 |
| 2023 | -49.68 |
| 2022 | -44.63 |
| 2021 | -34.76 |
| 2020 | -33.34 |
| 2019 | -46.31 |
| 2018 | -51.75 |
| 2017 | -74.38 |
| 2016 | -54.49 |
| 2015 | -41.36 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.38 |
| 2023 | 1.36 |
| 2022 | 1.24 |
| 2021 | 1.17 |
| 2020 | 1.14 |
| 2019 | 1.22 |
| 2018 | 1.11 |
| 2017 | 1.15 |
| 2016 | 1.10 |
| 2015 | 1.03 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
